One Political Plaza - Home of politics
Home Active Topics Newest Pictures Search Login Register
Main
NIH Refuses To Release Details Of C****-** V*****e Royalty Agreement
Apr 20, 2024 05:12:41   #
ACP45 Loc: Rhode Island
 
"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.

The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.

“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.

“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.

James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.

“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.

“There are a lot of NIH officials who resent t***sparency,” he added."

“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”

MY COMMENT: YA THINK!!!
https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge

Reply
Apr 20, 2024 05:19:22   #
AuntiE Loc: 45th Least Free State
 
ACP45 wrote:
"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.

The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.

“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.

“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.

James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.

“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.

“There are a lot of NIH officials who resent t***sparency,” he added."

“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”

MY COMMENT: YA THINK!!!
https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge
"The U.S. National Institutes of Health (NIH)... (show quote)


If one were to have access to NIH, HHS, and CDC upper level personnel’ investment portfolios, seeing their rate of return in their pharmaceutical investments would provide some information.

Reply
Apr 20, 2024 05:21:22   #
ACP45 Loc: Rhode Island
 
AuntiE wrote:
If one were to have access to NIH, HHS, and CDC upper level personnel’ investment portfolios, seeing their rate of return in their pharmaceutical investments would provide some information.


Indeed! Follow the money!

Reply
 
 
Apr 20, 2024 08:02:24   #
guzzimaestro
 
ACP45 wrote:
"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.

The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.

“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.

“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.

James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.

“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.

“There are a lot of NIH officials who resent t***sparency,” he added."

“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”

MY COMMENT: YA THINK!!!
https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge
"The U.S. National Institutes of Health (NIH)... (show quote)


Way back at the beginning, when it came out that the pharm companies couldn't be sued, I knew they were no good

Reply
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.
Main
OnePoliticalPlaza.com - Forum
Copyright 2012-2024 IDF International Technologies, Inc.